Vaccines

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

New simulations can help researchers design new drugs and vaccines to combat the coronavirus

Multiple avenues of research are underway to curb the COVID-19 pandemic  

Clinical trials for COVID-19 vaccines have begun around the world, and several other candidates are in development

Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates

WIRB-Copernicus IRB will give priority to the institutional review board (IRB) review of potentially life-saving COVID-19 vaccines and medications and waive their initial protocol review fees

Researchers'  work is providing crucial leads for guiding experimental efforts toward the vaccine development against the novel pneumonia (COVID-19) caused by the virus